Ian T. Clark, Director at Guardant Health, Inc. (GH), sold 18,292 shares at $89.78 ($1.6M) on 2020-09-08, disclosed to the SEC on 2020-09-10.
Open-market sale of $1.6M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.69 | 5,263 | $467K | 28.6% |
| 2 | $88.69 | 5,263 | $467K | 28.6% |
| 3 | $89.78 | 2,747 | $247K | 15.1% |
| 4 | $89.78 | 2,747 | $247K | 15.1% |
| 5 | $90.54 | 1,136 | $103K | 6.3% |
| 6 | $90.54 | 1,136 |
| $103K |
| 6.3% |
| Total | $89.25 avg | 18,292 | $1.6M | 100% |
| Filing → |
| OLMA | SELL | 2025-12-23 | $15.7M | — | Filing → |
| GH | SELL | 2025-12-08 | $5.8M | — | Filing → |
| GH | SELL | 2025-06-20 | $646K | — | Filing → |